Abiopharma

🔍 Jenisch Jan Philipp (Director)

Company: Amrize Ltd (AMRZ)

Report Date: 2026-09-02

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Ordinary Shares at $42.37 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,751,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 15,000 shares of Ordinary Shares at $42.53 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,766,000.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,000 shares of Ordinary Shares at $42.44 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,767,000.00 | transaction_form_type: 4
• Acquired 2,000 shares of Ordinary Shares at $42.53 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 517,000.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 2,000 shares of Ordinary Shares at $42.465 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 519,000.00 | transaction_form_type: 4

Footnotes:

• F1: The purchase was made in Swiss Francs at a price of CHF 34.53 per share, and such price was converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8149).
• F2: The purchase was made in Swiss Francs at a price of CHF 34.66 per share, and such price was converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8149).